A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 99 shares of CTLT stock, worth $6,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99
Previous 95 4.21%
Holding current value
$6,284
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$56.16 - $60.96 $224 - $243
4 Added 4.21%
99 $5,000
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $3,375 - $3,592
-63 Reduced 39.87%
95 $5,000
Q1 2024

Apr 30, 2024

BUY
$42.56 - $59.82 $6,724 - $9,451
158 New
158 $8,000
Q1 2023

May 10, 2023

SELL
$45.44 - $74.26 $185,304 - $302,832
-4,078 Reduced 37.36%
6,838 $449,000
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $130,502 - $255,393
3,153 Added 40.62%
10,916 $491,000
Q3 2022

Oct 26, 2022

BUY
$72.36 - $113.1 $68,235 - $106,653
943 Added 13.83%
7,763 $561,000
Q2 2022

Aug 10, 2022

SELL
$87.2 - $114.05 $80,398 - $105,154
-922 Reduced 11.91%
6,820 $731,000
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $4,521 - $5,975
48 Added 0.62%
7,742 $858,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $104,265 - $121,269
872 Added 12.78%
7,694 $985,000
Q3 2021

Nov 02, 2021

SELL
$109.17 - $142.35 $248,034 - $323,419
-2,272 Reduced 24.98%
6,822 $907,000
Q2 2021

Jul 27, 2021

BUY
$100.34 - $115.69 $44,049 - $50,787
439 Added 5.07%
9,094 $983,000
Q1 2021

May 11, 2021

BUY
$101.51 - $125.27 $68,113 - $84,056
671 Added 8.4%
8,655 $911,000
Q4 2020

Feb 09, 2021

BUY
$85.88 - $105.36 $81,929 - $100,513
954 Added 13.57%
7,984 $830,000
Q3 2020

Oct 20, 2020

BUY
$72.74 - $92.5 $32,005 - $40,700
440 Added 6.68%
7,030 $602,000
Q2 2020

Jul 02, 2020

SELL
$48.02 - $79.04 $4,321 - $7,113
-90 Reduced 1.35%
6,590 $483,000
Q1 2020

Apr 01, 2020

BUY
$36.95 - $62.95 $40,275 - $68,615
1,090 Added 19.5%
6,680 $347,000
Q4 2019

Feb 11, 2020

BUY
$47.06 - $56.64 $263,065 - $316,617
5,590 New
5,590 $314,000
Q4 2018

Feb 13, 2019

SELL
$29.95 - $46.34 $88,053 - $136,239
-2,940 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $21,263 - $24,141
-530 Reduced 15.27%
2,940 $134,000
Q2 2018

Aug 16, 2018

BUY
$38.72 - $42.52 $134,358 - $147,544
3,470 New
3,470 $145,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.